Regenerative Medical Technology Group, Inc. (RMTG), a regenerative medicine company, reported a 67% increase in sales for the first quarter of 2025 compared to the same period in 2024, with sales surpassing $1.35 million. The company also achieved an operating profit of $134,000 for the quarter. This growth is attributed to the introduction of a new revenue stream, namely Turnkey exclusive memberships. These memberships require new members to pay an upfront fee for assistance in setting up a regenerative medical clinic in their area, including continuous training and support, while committing to purchasing all supplies exclusively from RMTG. The company anticipates onboarding one new member per quarter, with plans to significantly increase this rate next year. Regenerative Medical Technology Group, Inc. plans to issue official guidance on revenues for the remainder of this year and the following two years in an upcoming press release.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Regenerative Medical Technology Group Inc. published the original content used to generate this news brief via ACCESS Newswire (Ref. ID: 1030131) on May 21, 2025, and is solely responsible for the information contained therein.
Comments